Mechanism of Astrin in head and neck squamous cell carcinoma

被引:3
|
作者
Wang, Jian [1 ]
Liu, Changjian [1 ]
Wei, Minghui [2 ,3 ]
机构
[1] Chinese Acad Med Sci & Peking Union Med Coll, Dept Head & Neck Surg, Natl Canc Ctr, Natl Clin Res Ctr Canc,Canc Hosp, Beijing, Peoples R China
[2] Chinese Acad Med Sci & Peking Union Med Coll, Dept Head & Neck Surg, Natl Canc Ctr, Natl Clin Res Ctr Canc,Canc Hosp, Shenzhen 518116, Peoples R China
[3] Chinese Acad Med Sci & Peking Union Med Coll, Shenzhen Hosp, Shenzhen 518116, Peoples R China
关键词
HNSCC; cell proliferation; cell migration; cell invasion; astrin antibody; EXPRESSION; SURVIVAL;
D O I
10.14715/cmb/2022.68.7.23
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Head and neck squamous cell carcinoma(HNSCC) is a malignant epidermal tumor that seriously threatens human life and health. The main factors affecting the death of patients are local recurrence and lymph node metastasis. Astrin antibody is the basic component of the mitotic spindle required for normal chromosome separation and later development. There are few domestic studies on the mechanism of Astrin in HNSCC. Based on this, this article is studying Astrin in HNSCC. The expression and function of Astrin, and analyze its correlation with clinical pathological parameters and prognosis of patients, and further explore the relevant mechanisms involved in the progression of Astrin in HNSCC. in this experiment, the real-time fluorescent quantitative polymerase chain reaction (PCR) method was used to detect the expression of the Astrin antibody in HNSCC cell lines A and B. Secondly, this article will focus on high metastatic HNSCC cells B. Divided into five groups (blank control group, overexpression positive group, overexpression negative control group, expression suppression positive group, expression suppression negative control group), using real-time fluorescent quantitative PCR technology to detect the expression of Astrin in each group, and then speculate the mechanism of Astrin in HNSCC. Experiments have shown that Astrin is expressed in A and B cells, but its expression in B is significantly higher than its expression in A, and the difference is statistically significant (P<0.001). This shows that the inhibition of Astrin expression has a significant anti-tumor effect and that Astrin plays an important role in the occurrence and development of tumors. It is expected to provide new ideas and reference basis for exploring new therapeutic strategies for targeted therapy of HNSCC. Copyright: (C) 2022 by the C.M.B. Association. All rights reserved.
引用
收藏
页码:141 / 147
页数:7
相关论文
共 50 条
  • [1] Head and neck squamous cell carcinoma
    不详
    [J]. Nature Reviews Disease Primers, 6 (1)
  • [2] Squamous cell carcinoma in the head and neck
    Al-Reefy, Hiba
    Dhar, Vikrain
    Dilkes, Mike
    [J]. BRITISH JOURNAL OF HOSPITAL MEDICINE, 2007, 68 (07) : 380 - 383
  • [3] HEAD AND NECK SQUAMOUS CELL CARCINOMA
    不详
    [J]. NATURE REVIEWS DISEASE PRIMERS, 2020, 6 (01):
  • [4] Squamous cell carcinoma of the head and neck
    Lorenz, K. J.
    Maier, H.
    [J]. HNO, 2008, 56 (04) : 402 - 409
  • [5] Mechanism and role of neutrophil recruitment in head and neck squamous cell carcinoma
    Ghias, Kulsoom
    Shakeel, Hina
    Sheikh, Alisalman
    Abidi, Syed Hani
    Masood, Kiran I.
    Fatima, Saira
    Bilwani, Fareena
    [J]. CANCER RESEARCH, 2023, 83 (07)
  • [6] Biomarkers of squamous cell carcinoma of the head and neck
    Kim, J
    Shin, DM
    [J]. HISTOLOGY AND HISTOPATHOLOGY, 1997, 12 (01) : 205 - 218
  • [7] Immunotherapy for Head and Neck Squamous Cell Carcinoma
    Moskovitz, Jessica
    Moy, Jennifer
    Ferris, Robert L.
    [J]. CURRENT ONCOLOGY REPORTS, 2018, 20 (02)
  • [8] Afatinib in squamous cell carcinoma of the head and neck
    Specenier, Pol
    Vermorken, Jan
    [J]. EXPERT OPINION ON PHARMACOTHERAPY, 2016, 17 (09) : 1295 - 1301
  • [10] Head and neck squamous cell carcinoma in childhood
    de Carvalho, MB
    Sobrinho, JD
    Rapoport, A
    Fava, AS
    Mendes, AF
    Kanda, JL
    Lehn, CN
    Chacra, J
    Menezes, MB
    Walder, F
    Franzi, SA
    [J]. MEDICAL AND PEDIATRIC ONCOLOGY, 1998, 31 (02): : 96 - 99